Plain-English translation of NCT07218276 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a small study testing whether simple, affordable robotic devices can help stroke survivors regain better use of their arms and hands. The devices being tested—called SepaRRo and NeuRRoFES—are designed to be used at home and combine gentle robotic assistance with electrical nerve stimulation. The goal is to see if these low-cost tools work as well as expensive hospital robots, but in a way that's practical for everyday people.
Most stroke survivors struggle with arm weakness and loss of hand function, and while expensive robotic therapy can help, it's not available to most people because the equipment is too costly and bulky. This trial is trying to prove that simpler, cheaper devices can deliver similar benefits and be used safely at home.
You likely qualify if…
You likely don't qualify if…
You would visit the research team 2 to 5 times per week for 2 to 6 weeks to use the robotic devices under supervision. During each session, you would work with the SepaRRo tabletop equipment, which gently assists or resists your arm movements, while the NeuRRoFES system delivers electrical stimulation to your muscles during functional tasks. The team will measure how well you tolerate the treatment, whether you can complete the exercises, and whether your arm function improves.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States
Sponsor
University of Michigan
Enrollment target
~4 participants
Started
November 2025
Primary completion
October 2027
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chandramouli Krishnan, PT, PhD
University of Michigan
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.